Gene · 710
NIH grants1,786
NIH grants whose papers are about the gene, through NIH's grant-paper links.
581 to 600 of 1,786
Download this page as JSON| Grant | Title | SERPING1 papers | Newest fiscal year |
|---|---|---|---|
| R01HL094450 | Sodium Channels and Cardiac Arrhythmias | 1 | 2022 |
| R01HL139641 | New genetic models for C5a receptors | 1 | 2022 |
| R01HL139731 | Genomics of Cardiac Arrhythmias | 1 | 2022 |
| R01HL147565 | IL-35 inhibits gut microbiota-produced uremic toxin-accelerated endothelial cell activation | 1 | 2022 |
| R01HS026732 | Health Information Exchange Utilization and Inter-hospital Transfer Outcomes | 1 | 2022 |
| R01MH109715 | Mapping the role of long noncoding RNAs in gene regulatory networks in schizophrenia | 1 | 2022 |
| R01NS104147 | Cerebral amyloid angiopathy fluid biomarkers evaluation (CAFE) | 1 | 2022 |
| R03AG070480 | Impact of apolipoprotein E isoforms on brain lipoproteins | 1 | 2022 |
| R03CA256764 | Radiation and CSPG4-specifc CAR T cell based combinatorial therapy for the in vivo treatment of TNBC | 1 | 2022 |
| R21HD104071 | A new animal model for investigating the invasive trophoblast lineage | 1 | 2022 |
| R24AA022057 | Mouse Models and Metabolomics Tools to Investigate Alcohol Metabolism and Tissue Injury | 1 | 2022 |
| R24GM136984 | Transitioning GLYCAM-Web to a self-sustaining carbohydrate modeling service | 1 | 2022 |
| R25HL092611 | MUSC Short Term Research Education Program to Increase Diversity | 1 | 2022 |
| R50CA232985 | Targeting the Immunosuppressive Tumor Microenvironment in Pancreatic Cancer | 1 | 2022 |
| RF1NS085002 | Cerebral Small Vessels in Motor and Cognitive Decline: Neuroimaging Signatures of Vulnerability & Resilience | 1 | 2022 |
| SC3GM131986 | Inhibitors of the Intrinsic Pathway of Coagulation as New Anticoagulants | 1 | 2022 |
| T32DK007126 | Renal Disease | 1 | 2022 |
| T32DK007541 | Molecular Biological Approaches to Endocrinology | 1 | 2022 |
| T32DK007757 | Mount Sinai Nephrology Research Training Grant | 1 | 2022 |
| T32GM008061 | Cellular and Molecular Basis of Disease Training Program | 1 | 2022 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/710/grants?page=30